Written by Gary
Small caps are taking a beating while the large caps (DOW) is flat. Nasdaq is down 1.3%, DOW down 0.1%, and the SP500 down 0.65%. Crude is up a whopping 4.3%, U.S. dollar down 0.7% and gold up 0.9%. Something to watch are the near-term double tops and inverse ETF’s double bottoms. Crude is approaching a resistance / double top and the U.S. dollar is dangerously close to breaking through an up-trend line. Now is NOT the time to take chances going long with so many negatives abound.
Here is the current market situation from CNN Money | |
North and South American markets are mixed today. The Bovespa is up 5.42% while the IPC gains 0.10%. The S&P 500 is off 0.58%. |
Traders Corner – Health of the Market
Index | Description | Current Value |
Investors.com Members Sentiment: | % Bullish (the balance is Bearish) | 64% |
CNN’s Fear & Greed Index | Above 50 = greed, below 50 = fear | 30% |
Investors Intelligence sets the breath | Above 50 bullish | 28.7% |
StockChart.com Overbought / Oversold Index ($NYMO) | anything below -30 / -40 is a concern of going deeper. Oversold conditions on the NYSE McClellan Oscillator usually bounce back at anything over -50 and reverse after reaching +40 oversold. | 58.7 |
StockChart.com NYSE % of stocks above 200 DMA Index ($NYA200R) | $NYA200R chart below is the percentage of stocks above the 200 DMA and is always a good statistic to follow. It can depict a trend of declining equities which is always troubling, especially when it drops below 60% – 55%. Dropping below 40%-35% signals serious continuing weakness and falling averages. | 26.52% |
StockChart.com NYSE Bullish Percent Index ($BPNYA) | Next stop down is ~57, then ~44, below that is where we will most likely see the markets crash. | 36.37% |
StockChart.com S&P 500 Bullish Percent Index ($BPSPX) | In support zone and rising. ~62, ~57, ~45 at which the markets are in a full-blown correction. | 38.80% |
StockChart.com 10 Year Treasury Note Yield Index ($TNX) | ten year note index value | 20.40 |
StockChart.com Consumer Discretionary ETF (XLY) | As long as the consumer discretionary holds above [66.88], all things being equal, it is a good sign for stocks and the U.S. economy | 76.18 |
StockChart.com NYSE Composite (Liquidity) Index ($NYA) | Markets move inverse to institutional selling and this NYA Index is followed by Institutional Investors | 10,130 |
What Is Moving the Markets
Here are the headlines moving the markets. | |
Big U.S. firms hold $2.1 trillion overseas to avoid taxes: study WASHINGTON (Reuters) – The 500 largest American companies hold more than $2.1 trillion in accumulated profits offshore to avoid U.S. taxes and would collectively owe an estimated $620 billion in U.S. taxes if they repatriated the funds, according to a study released on Tuesday. | |
Oil hits month-high; eyes on less output, Saudi-Russia talks NEW YORK (Reuters) – Crude prices hit one-month highs on Tuesday after a new U.S. forecast showed tighter oil supplies next year, while and Russia, Saudi Arabia and other big producers hinted at further talks to support the market. | |
Goldman, Morgan Stanley win back hedge fund trading business NEW YORK (Reuters) – Goldman Sachs and Morgan Stanley are winning back the trading business of hedge fund clients that they lost to European rivals during the financial crisis, as new capital rules spur banks like Deutsche Bank to scale down their businesses. The two U.S. banks together now have about 37 percent of the market for trading with hedge funds and financing positions, known as “prime brokerage,” up about 6 percentage points from the end of last year, according to research firm Preq | |
Wall St. moves lower as global growth worries resurface (Reuters) – The S&P and the Nasdaq fell on Tuesday morning as worries about economic growth resurfaced at U.S. companies begin to report quarterly results, while a surge in DuPont helped the Dow move higher. | |
VW under pressure for answers as emissions scandal deadlines loom WOLFSBURG, Germany (Reuters) – Hans Dieter Poetsch’s first board meeting as chairman of Volkswagen on Wednesday could turn out to be his most important, coming just hours before a deadline set by German regulators and testimony by the company’s top U.S. executive in Congress. | |
U.S. trade deficit widens as exports sag, imports from China surge WASHINGTON (Reuters) – U.S. exports took a hit from an ailing global economy in August and imports from China surged, fueling the largest expansion of America’s trade deficit in five months. | |
IMF cuts global growth forecasts again, cites commodity and China worries LIMA (Reuters) – The International Monetary Fund cut its global growth forecasts for a second time this year on Tuesday, citing weak commodity prices and a slowdown in China and warned that policies aimed at increasing demand were needed. | |
One Trader Says Central Banks Need To Just Shut UpOn Monday, in “Central Banks Now In ‘Dangerous Situation’: ‘You’ve Thrown The Kitchen Sink At It, What’s Next?'”, we said the following about the global fiat confidence game:
Well, we aren’t the only ones with serious questions about just how long this charade can hold up and indeed, when traders start questioning the central planner narrative, it’s proof positive that said narrative has been lost. On that note we bring you the following from Bloomberg’s Richard Breslow, the man who, you’re reminded, is also concerned about whether Janet Yellen has the proper training to serve as the market’s “head trader”: … | |
Momo Massacre: Biotechs Are Crashing, Turn Red For 2015On Sunday, after the latest NYT piece by Andrew Pollack focusing on the “astronomical” prices increases by Valeant we made a simple observation: “More Pain For Biotechs Ahead: Valeant’s “Astronomical” Price Increases Take Center Stage; Pfizer Gets Dragged In.” Sure enough, on Monday Valeant promptly crashed over 10% as the second round of concerns about price caps emerged. Then, this morning, the attack against biotech price gouging became two-pronged when this time the WSJ joined in the NYT with an article overnight “For Prescription Drug Makers, Price Increases Drive Revenue” in which the topic was familiar to those following the interplay between “astronomical” biotech prices and the imminent congressional crackdown on said prices:
For those wondering, the tone’s article was not conducive to further upside in the … | |
Glencore Explains What Would Happen If It Is Downgraded To JunkAs part of its ongoing scramble to defend itself against “speculators” and concerns about its balance sheet, earlier today Glencore released a 4 page “funding worksheet” detailing all of its obligations. Among the highlights was Glencore’s disclosure of total available liquidity as of this moment, which the firm reported to be materially above its June level of $10.5 billion:
It also presented its sources of funding among which the well-known $31.1 billion in bonds, as well as $20 billion in short-term funding split between a $15.25 revolver (of which a “substantial portion” is undrawn), $1.2 billion in AR/Inventory secured funding, and $3.4 billion in bilateral bank facilities. Glencore was quick to point out the gullibility of its bank lenders: “No financial covenants, no rating events of default or rating prepayment events, no material adverse change events of default or material adverse change prepayment events.” Next Glencore details the terms of its notes and cross-guarantees which it lays out as follows:
| |
Saudi Clerics Call For Jihad Against Russia, Iran; NATO Warns Of Airspace “Violations”It’s now been nearly a week since Russia began its air campaign in Syria and as we’ve documented extensively, both Moscow and the West have put their respective propaganda machines into high gear in an effort to control the narrative and thus dictate how history will remember Syria’s four-year-old, bloody civil war. Lacking viable options in the face of Russia’s rapid military deployment at Latakia, the US has turned to the only thing left in the spin toolbox: the contention that Moscow’s airstrikes are hitting the “good†guys. Here’s WSJ:
| |
Global Stocks Lose MomentumA selloff in health-care stocks deepened in midday trading Tuesday, threatening to overshadow a crude-oil rally that lifted energy stocks. | |
Glencore Reveals Financing DealsGlencore has launched a salvo against critics who say the firm’s books are too opaque, publishing details of its financing arrangements with banks and other creditors and the potential impact of credit-rating downgrades. |
Earnings Summary for Today
leading Stock Positions
Current Commodity Prices
Commodities are powered by Investing.com
Current Currency Crosses
The Forex Quotes are powered by Investing.com.
To contact me with questions, comments or constructive criticism is always encouraged and appreciated: